Actelion Pharmaceuticals Reports New OPSUMIT (macitentan) Data Show Initial Combination Therapy with Tadalafil Improved Hemodynamic Clinical & Functional Parameters in Patients with PAH
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Drug firms avert landmark opioid trial as talks on $48-billion settlement set to resume
October 21, 2019 7:14 AM EDTBy Kathy Gray
CLEVELAND (Reuters) - Four large drug companies could resume talks on Tuesday to try to reach a $48 billion settlement of all opioid litigation against them, after agreeing with two Ohio counties to a $260 million deal to avert the first federal trial over their role in the U.S. opioid epidemic.
Drug distributors AmerisourceBergen Corp, Cardinal Health Inc and McKesson Corp and drugmaker Teva Pharmaceutical Industries Ltd agreed to the deal that removed the immediate threat of a trial that was to begin on Monday in Cleveland.
The parties could resume talks as... More
Johnson & Johnson (JNJ) Ticks Off Lows on Analyst Defense
October 18, 2019 1:32 PM EDTJohnson & Johnson (NYSE: JNJ) ticks off lows with the stock being defended at Credit Suisse. Shares remain down 5.2% following news the company recalled a lot of baby powder after traces of asbestos was found.
... MoreJohnson & Johnson (JNJ) Trades at Low, Down 5%
October 18, 2019 12:20 PM EDTJohnson & Johnson (NYSE: JNJ) Trades at Low, Down 5%
... MoreJohnson & Johnson (JNJ) put volume and IV up as shares sell off 4%
October 18, 2019 11:33 AM EDTJohnson & Johnson (NYSE: JNJ) October call option implied volatility is at 49, November is at 22; compared to its 52-week range of 14 to 34 into voluntarily recalling single lot of Baby Powder in U.S. Call put ratio 1 call to 2 puts.
... MoreJohnson & Johnson (JNJ) option implied volatility increases as shares sell off 3% on recalling single lot of Baby Powder
October 18, 2019 9:49 AM EDTJohnson & Johnson (NYSE: JNJ) October call option implied volatility is at 53, November is at 20; compared to its 52-week range of 14 to 34 into voluntarily recalling single lot of Baby Powder in U.S. Call put ratio 1 call to 2.3 puts with focus on October 130 and 132 puts.
... MoreJohnson & Johnson (JNJ) IV low into voluntarily recalling single lot of Baby Powder in U.S.
October 18, 2019 9:14 AM EDTJohnson & Johnson (NYSE: JNJ) October call option implied volatility is at 17, November is at 16; compared to its 52-week range of 14 to 34 into voluntarily recalling single lot of Baby Powder in U.S.
... MoreJ&J (JNJ) Extends Decline, Now Down 3.4% After Baby Powder Recall Tied to Traces of Asbestos
October 18, 2019 9:09 AM EDTJ&J (NYSE: JNJ) Extends Decline, Now Down 3.4% After Baby Powder Recall Tied to Traces of Asbestos
J&J (JNJ) to Recall Single Lot Of Johnson's Baby Powder in U.S. After Test Indicates Presence of Sub-trace Levels of Chrysotile Asbestos
October 18, 2019 8:40 AM EDT(Updated - October 18, 2019 8:44 AM EDT)
Out of an abundance of caution, Johnson & Johnson Consumer Inc. (JJCI) (NYSE: JNJ) announced that it is initiating a voluntary recall in the United States of a single lot of its Johnson's Baby Powder in response to a U.S. Food and Drug Administration (FDA) test indicating the presence of sub-trace levels of chrysotile asbestos contamination (no greater than 0.00002%) in samples from a single bottle purchased from an online retailer. Despite the low levels reported and in full cooperation and collaboration... More
Boeing, J&J, dismal China data drag Wall Street lower
October 18, 2019 7:47 AM EDTBy Stephen Culp
NEW YORK (Reuters) - Wall Street fell on Friday as negative headlines about Johnson & Johnson and Boeing, along with bleak economic data from China, soured investor risk appetite and offset generally positive corporate earnings.
All three major U.S. stock averages ended the session in the red, but the S&P 500 and the Nasdaq posted weekly gains. The blue-chip Dow was nominally lower than last week's close.
Boeing Co (NYSE: BA) and Johnson & Johnson (NYSE: JNJ) shares led both the S&P 500's and the Dow's... More
NY AG Says Johnson & Johnson (JNJ) Subsidiary to Pay $117M in Women's Health Settlement
October 17, 2019 2:01 PM EDTNew York Attorney General Letitia James today announced a multistate settlement, along with 41 additional attorneys general, requiring Johnson & Johnson (NYSE: JNJ) and its subsidiary Ethicon, Inc. to pay nearly $117 million for the deceptive marketing of transvaginal surgical mesh devices that endangered the health of women across New York and the rest of the nation. A multistate investigation found the companies violated state consumer protection laws by misrepresenting the safety and effectiveness of the devices and failing to sufficiently disclose risks associated with their use.
Health and safety must come before profits, Attorney General James... More
Johnson & Johnson (JNJ) Declares $0.95 Quarterly Dividend; 2.8% Yield
October 17, 2019 11:46 AM EDTJohnson & Johnson (NYSE: JNJ) declared a quarterly dividend of $0.95 per share, or $3.8 annualized.
The dividend will be payable on December 10, 2019, to stockholders of record on November 26, 2019, with an ex-dividend date of November 25, 2019.
The annual yield on the dividend is 2.8 percent.
For a... More
